Supratentorial ependymoma in children: To observe or to treat following gross total resection?

Pediatric Blood and Cancer

Volumn 58, Issue 3, 2012, Pages 380-383

  Venkatramani, Rajkumar ^a   Dhall, Girish ^a   Patel, Moneil ^a   Grimm, John ^a   Hawkins, Cynthia ^b   Mccomb, Gordon ^a   Krieger, Mark ^a   Wong, Kenneth ^a   O'Neil, Sharon ^a   Finlay, Jonathan L ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Ependymoma; Observation; Supratentorial; Surgery

Indexed keywords

ANTICONVULSIVE AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DRUG MEGADOSE; EPENDYMOMA; FEMALE; FOLLOW UP; HEARING LOSS; HEMIPARESIS; HISTOLOGY; HUMAN; IRRADIATION; MALE; MEDICAL RECORD REVIEW; NEUROSURGERY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SEIZURE; TREATMENT RESPONSE; TUMOR LOCALIZATION; VISUAL FIELD DEFECT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMANS; INFANT; MALE; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL ANALYSIS; WATCHFUL WAITING;

EID: 84855787064     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23086     Document Type: Article

References (30)

1. Kun LE, Kovnar EH, Sanford RA. Ependymomas in children. Pediatr Neurosci 1988; 14: 57-63.
2. McGuire CS, Sainani KL, Fisher PG. Incidence patterns for ependymoma: A surveillance, epidemiology, and end results study. J Neurosurg 2009; 110: 725-729.
3. Zacharoulis S, Moreno L. Ependymoma: An update. J Child Neurol 2009; 24: 1431-1438.
4. Hukin J, Epstein F, Lefton D, et al. Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg 1998; 29: 40-45.
5. Palma L, Celli P, Mariottini A, et al. The importance of surgery in supratentorial ependymomas. Childs Nerv Syst 2000; 16: 170-175.
6. Tabori U, Ma J, Carter M, et al. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma. J Clin Oncol 2006; 24: 1522-1528.
7. Perilongo G, Massimino M, Sotti G, et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol 1997; 29: 79-85.
8. Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: Long-term outcome and prognostic factors. Neurosurgery 1995; 37: 655-666 (discussion 666-667).
9. Grill J, Le Deley M, Gambarelli D, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A Multicenter Trial of the French Society of Pediatric Oncology. J Clin Oncol 2001; 19: 1288-1296.
10. Merchant TE, Haida T, Wang M, et al. Anaplastic ependymoma: Treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 1997; 86: 943-949.
11. Vanuytsel L, Brada M. The role of prophylactic spinal irradiation in localized intracranial ependymoma. Int J Radiat Oncol Biol Phys 1991; 21: 825-830.
12. McGuire CS, Sainani KL, Fisher PG. Both location and age predict survival in ependymoma: A SEER study. Pediatr Blood Cancer 2009; 52: 65-69.
13. Merchant TE, Li C, Xiong X, et al. Conformal radiotherapy after surgery for paediatric ependymoma: A prospective study. Lancet Oncol 2009; 10: 258-266.
14. Horn B, Heideman R, Geyer R, et al. A multi-institutional retrospective study of intracranial ependymoma in children: Identification of risk factors. J Pediatr Hematol Oncol 1999; 21: 203-211.
15. Robertson PL, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: A report of the Children's Cancer Group. J Neurosurg 1998; 88: 695-703.
16. Bouffet E, Perilongo G, Canete A, et al. Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 1998; 30: 319-329 (discussion 329-331).
17. Ernestus RI, Wilcke O, Schröder R. Supratentorial ependymomas in childhood: Clinicopathological findings and prognosis. Acta Neurochir 1991; 111: 96-102.
18. Conklin HM, Li C, Xiong X, et al. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol 2008; 26: 3965-3970.
19. Kiehna EN, Mulhern RK, Li C, et al. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol 2006; 24: 5283-5290.
20. Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, et al. Adjuvant chemotherapy of childhood posterior fossa ependymoma: Cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: A Childrens Cancer Group study. Med Pediatr Oncol 1996; 27: 8-14.
21. Grundy RG, Wilne SA, Weston CL, et al. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: The UKCCSG/SIOP prospective study. Lancet Oncol 2007; 8: 696-705.
22. Geyer JR, Sposto R, Jennings M, et al. Multiagent Chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the Children's Cancer Group. J Clin Oncol 2005; 23: 7621-7631.
23. Massimino M, Gandola L, Barra S, et al. Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy. Int J Radiat Oncol Biol Phys 2010; DOI: 10.1016/j.ijrobp.2010.02.048.
24. Gerszten PC, Pollack IF, Martínez AJ, et al. Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. Pathol Res Pract 1996; 192: 515-522.
25. Messahel B, Ashley S, Saran F, et al. Relapsed intracranial ependymoma in children in the UK: Patterns of relapse, survival and therapeutic outcome. Eur J Cancer (Oxf, Engl 1990) 2009; 45: 1815-1823.
26. Massimino M, Giangaspero F, Garrè ML, et al. Salvage treatment for childhood ependymoma after surgery only: Pitfalls of omitting "at once" adjuvant treatment. Int J Radiat Oncol Biol Phys 2006; 65: 1440-1445.
27. Korshunov A, Witt H, Hielscher T, et al. Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 2010; 28: 3182-3190.
28. Afra D, Muller W, Slowik F, et al. Supratentorial lobar ependymomas: Reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir 1983; 69: 243-251.
29. Vinchon M, Soto-Ares G, Riffaud L, et al. Supratentorial ependymoma in children. Pediatr Neurosurg 2001; 34: 77-87.
30. Zacharoulis S, Levy A, Chi SN, et al. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer 2007; 49: 34-40.